Merz acquires BioForm Medical
Tender offer sets Merz up to acquire BioForm Medical in a USD 253 million transaction.
Merz and BioForm Medical have approved a definitive agreement under which Merz will acquire all of the outstanding shares of BioForm Medical for USD 5.45 per share in cash. The transaction has a total equity value of approximately USD 253 million based on BioForm Medical's outstanding shares of common stock.
Following completion of the tender offer, Merz's acquisition subsidiary will merge with BioForm Medical, with BioForm Medical surviving the merger as a wholly-owned subsidiary of Merz being renamed Merz Aesthetics. Merz will set about a second-step merger in which any remaining BioForm Medical stockholders will receive the same price per share paid in the tender offer.
Read more
| Fund | Teknoinvest VIII Argentum share 32.4% |
| Portfolio Company | BioForm |
| Date of Transaction | 2010-01-04 |
| Transaction | Trade-sale |
| Seller | |
| Buyer | Merz |
| Size of Transaction | USD 253.0m |
| Ind. Focus | Life Science |
| Geography | USA |
| Stage | Venture |